BioClinica, Inc.,
a global provider of clinical trial management services, will exhibit at the 46th Drug Information Association (DIA) Annual Meeting from June 13- 17, 2010 in Washington, D.C., where it will showcase the BioClinica eClinical Technology Suite as well as introduce the BioClinica Integrated Operations Platform (BIOP). This advancement in clinical support technology uses Microsoft Office and SharePoint platforms to deliver a real world window on clinical operations.
This development will enable BioClinica to make operational data accessible in Microsoft Office and SharePoint applications that most customers already use.
“Our customers told us that they needed a simpler way to centralize and share their operational data for managing clinical trials. Through our work with Microsoft we are embracing the SharePoint and Office tools that many customers already have and use. Unlike other solutions, this platform untethers the clinical data, making the data more easily accessible and therefore more usable,"said Mark Weinstein, CEO of BioClinica.
The SharePoint platform delivers increased workflow efficiencies among life sciences colleagues, partners and customers. BioClinica CTMS utilizes SharePoint, creating customer oversight to eClinical workflow and access to data and reports through the Microsoft Office platform.
“To keep up with market demands, life sciences companies are under increased pressure to speed the pace of clinical trials and quickly bring new drugs to market,” said Michael Naimoli, director of life sciences industry solutions, Microsoft. “With the integration of our Office and SharePoint platforms, BioClinica customers can liberate their data for a comprehensive, real-time view into studies and pertinent information, with Office Smart clinical trial management systems.”
Zenocutuzumab Shows Durable Efficacy in NRG1 Fusion-Positive Cancers in Phase II eNRGy Trial
February 13th 2025The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 fusion–positive cancers, particularly non-small cell lung cancer and pancreatic cancer.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.